FluGen CEO talks Covid-19 vaccine development

At Wisconsin Inno’s latest virtual event, Paul Radspinner, the president and CEO of FluGen, revealed the startup’s progress on developing a Covid-19 vaccine as the pandemic rages on its seventh month.

The event, which took place Sept. 29, focused on FluGen’s unique approach to developing vaccines, what the biggest challenges are in making them, and what vaccine-makers need to do to ensure patients they are safe and effective.

Shortly after the pandemic began, the Madison biopharmaceutical startup began working with the University of Wisconsin-Madison and India-based Bharat Biotech to develop and test a vaccine for Covid-19.

Read the full article at: https://www.bizjournals.com/milwaukee/inno/stories/inno-events/2020/09/30/flugen-ceo-talks-covid-19-vaccine-development-in-b.html